Study on Neurodevelopmental Outcomes After In Utero Lyme Disease Exposure Launched
A pilot study has been initiated to evaluate the neurodevelopmental outcomes of infants exposed to Lyme disease in utero.
Indication
Clinical and regulatory intelligence for Lyme Disease with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.